U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06813118) titled 'Comparison of Clomid and Lezra with Lezra for Ovulation Induction in Clomid Resistant PCOS Case' on Sept. 13, 2024.
Brief Summary: Clomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickness will be checked by transvaginal ultrasound and results will be recorded.
Study Start Date: June 07, 2024
Study Type: INTERVENTIONAL
Condition:
Polycystic Ovarian Syndrome
Intervention:
DRUG: Clomiphene Citrate and letroz...